Evolution of rifampicin treatment for tuberculosis
M Grobbelaar, GE Louw, SL Sampson… - Infection, Genetics and …, 2019 - Elsevier
Rifampicin was discovered in 1965 and remains one of the most important drugs in
tuberculosis treatment that is valued for its sterilizing activity and ability to shorten treatment …
tuberculosis treatment that is valued for its sterilizing activity and ability to shorten treatment …
Dry powder inhalers of antitubercular drugs
N Nainwal, Y Sharma, V Jakhmola - Tuberculosis, 2022 - Elsevier
Despite advancements in the medical and pharmaceutical fields, tuberculosis remains a
major health problem globally. Patients do not widely accept the conventional approach to …
major health problem globally. Patients do not widely accept the conventional approach to …
Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis
Current treatment therapeutic approach for tuberculosis is the administration of first line
drugs in the form of tablets and capsules for 4–6 months. However, this approach leads to …
drugs in the form of tablets and capsules for 4–6 months. However, this approach leads to …
Fluorescent folic acid-capped copper nanoclusters for the determination of rifampicin based on inner filter effect
Y Zhang, Q Deng, C Tang, M Zhang, Z Huang… - Spectrochimica Acta Part …, 2023 - Elsevier
Abstract Development of excellent sensors to determine trace concentrations of rifampicin is
of intense importance for medicine analysis and human health. Herein, a facile and green …
of intense importance for medicine analysis and human health. Herein, a facile and green …
Potential of dry powder inhalers for tuberculosis therapy: facts, fidelity and future
Tuberculosis (TB) is a contagious and airborne infectious disease caused by the pathogen
Mycobacterium tuberculosis (Mtb). In spite of substantial research efforts, continuous …
Mycobacterium tuberculosis (Mtb). In spite of substantial research efforts, continuous …
Novel approaches for the treatment of pulmonary tuberculosis
Tuberculosis (TB) is a contagious airborne disease caused by Mycobacterium tuberculosis,
which primarily affects human lungs. The progression of drug-susceptible TB to drug …
which primarily affects human lungs. The progression of drug-susceptible TB to drug …
Ferulic acid-loaded drug delivery systems for biomedical applications
Abstract Approximately 40% and 90% of the drugs developed and in the developing phase,
suffer from poor aqueous solubility, and thereby exhibiting declined oral bioavailability and …
suffer from poor aqueous solubility, and thereby exhibiting declined oral bioavailability and …
Development of novel octanoyl chitosan nanoparticles for improved rifampicin pulmonary delivery: optimization by factorial design
A novel hydrophobic chitosan derivative, octanoyl chitosan (OC) with improved organic
solubility was synthesized, characterized, and employed for the preparation of rifampicin …
solubility was synthesized, characterized, and employed for the preparation of rifampicin …
Phenylboronic acid functionalized high-crystallinity fluorescent covalent organic framework act as a sensing platform with dual performance for rifamycin antibiotics …
L Wang, D Wang, Y Tao, J Wang, M Tian, Q Liu… - Materials Today …, 2023 - Elsevier
Phenylboronic acid functionalized high-crystallinity fluorescent covalent organic framework
(BA@ COF), which can be applied for rifamycin antibiotics and water sensing, and for …
(BA@ COF), which can be applied for rifamycin antibiotics and water sensing, and for …
A review on recent advances in nanomedicines for the treatment of pulmonary tuberculosis
Tuberculosis (TB) has been the most life-threatening contagious disease caused by
pathogenic mycobacterium tuberculosis. The World Health Organization (WHO) report, 2020 …
pathogenic mycobacterium tuberculosis. The World Health Organization (WHO) report, 2020 …